Therapeutic Area | MeSH |
---|---|
eye diseases | D005128 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
retinal diseases | — | D012164 | H35.9 |
Code | Description |
---|---|
J7316 | Injection, ocriplasmin, 0.125 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Stroke | D020521 | EFO_0000712 | I63.9 | 16 | 44 | 48 | 13 | 50 | 159 |
Ischemic stroke | D000083242 | — | — | 12 | 47 | 53 | 18 | 33 | 149 |
Ischemia | D007511 | EFO_0000556 | — | 7 | 14 | 11 | 5 | 14 | 48 |
Thrombosis | D013927 | — | — | 3 | 4 | 11 | 6 | 8 | 31 |
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | 3 | 15 | 7 | 6 | 30 |
Pulmonary embolism | D011655 | EFO_0003827 | I26 | — | 4 | 9 | 10 | 6 | 29 |
Cerebral infarction | D002544 | — | I63 | 3 | 11 | 7 | 3 | 6 | 26 |
Infarction | D007238 | EFO_0009463 | — | — | 3 | 8 | 6 | 7 | 23 |
Hemorrhage | D006470 | MP_0001914 | R58 | 2 | 1 | 3 | 5 | 11 | 22 |
Embolism | D004617 | — | — | 1 | 1 | 2 | 4 | 4 | 12 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Tissue adhesions | D000267 | — | — | — | 3 | 4 | — | 4 | 11 |
Arterial occlusive diseases | D001157 | EFO_0009085 | — | — | 3 | 5 | — | 2 | 10 |
Cerebral hemorrhage | D002543 | — | — | 1 | 4 | 2 | — | 2 | 9 |
Neoplasms | D009369 | — | C80 | 2 | 3 | 2 | — | 2 | 7 |
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 2 | 6 | — | — | 7 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 6 | — | 1 | 7 |
Blood coagulation disorders | D001778 | EFO_0009314 | D68.9 | — | — | 1 | — | 5 | 6 |
Hemostatic disorders | D020141 | — | — | — | — | 1 | — | 5 | 6 |
Respiratory distress syndrome | D012128 | EFO_1000637 | J80 | 1 | 2 | 3 | — | 1 | 6 |
Coronary disease | D003327 | — | — | — | — | 5 | — | 1 | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Macular edema | D008269 | — | — | 2 | 2 | — | — | 1 | 4 |
Brain infarction | D020520 | EFO_0004277 | I63 | — | 3 | — | — | 1 | 4 |
Vitreous detachment | D020255 | EFO_1001238 | H43.81 | — | 1 | — | — | 2 | 3 |
Respiratory insufficiency | D012131 | — | J96.9 | — | 3 | — | — | — | 3 |
Vitrectomy | D014821 | — | — | — | 3 | — | — | — | 3 |
Head and neck neoplasms | D006258 | — | — | — | 1 | — | — | 2 | 3 |
Healthy volunteers/patients | — | — | — | 1 | 1 | — | — | — | 2 |
Hypertensive intracranial hemorrhage | D020299 | — | — | — | 1 | — | — | 1 | 2 |
Communicable diseases | D003141 | — | — | — | 1 | — | — | 1 | 2 |
Intracranial vasospasm | D020301 | EFO_1000994 | G45.9 | 1 | 1 | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Prostatic neoplasms | D011471 | — | C61 | 2 | — | — | — | 1 | 3 |
Retinal vein occlusion | D012170 | EFO_1001157 | H34.81 | 3 | — | — | — | — | 3 |
Urinary bladder neoplasms | D001749 | — | C67 | 2 | — | — | — | 1 | 3 |
Malignant pleural effusion | D016066 | — | J91.0 | 1 | — | — | — | — | 1 |
Thrombophlebitis | D013924 | — | — | 1 | — | — | — | — | 1 |
Adjuvant chemotherapy | D017024 | — | — | 1 | — | — | — | — | 1 |
Gallstones | D042882 | EFO_0004210 | — | 1 | — | — | — | — | 1 |
Cholelithiasis | D002769 | EFO_0004799 | K80 | 1 | — | — | — | — | 1 |
Cholecystolithiasis | D041761 | EFO_1000864 | — | 1 | — | — | — | — | 1 |
Vision disorders | D014786 | — | H53.11 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sepsis | D018805 | EFO_0001420 | A41.9 | — | — | — | — | 7 | 7 |
Toxemia | D014115 | — | — | — | — | — | — | 7 | 7 |
Periodontitis | D010518 | EFO_0000649 | K05.3 | — | — | — | — | 6 | 6 |
Fibrinolysis | D005342 | — | — | — | — | — | — | 3 | 3 |
Chronic periodontitis | D055113 | EFO_0006343 | K05.3 | — | — | — | — | 3 | 3 |
Acute kidney injury | D058186 | — | N17 | — | — | — | — | 3 | 3 |
Rupture | D012421 | — | — | — | — | — | — | 2 | 2 |
Coagulation protein disorders | D020147 | — | — | — | — | — | — | 2 | 2 |
Mortality | D009026 | EFO_0004352 | — | — | — | — | — | 2 | 2 |
Thrombotic stroke | D000083244 | — | — | — | — | — | — | 2 | 2 |
Drug common name | Ocriplasmin |
INN | ocriplasmin |
Description | Ocriplasmin, sold under the brand name Jetrea, is a recombinant protease with activity against fibronectin and laminin, components of the vitreoretinal interface. It is used for treatment of symptomatic vitreomacular adhesion, for which it received FDA approval on 17 October 2012. It works by dissolving the proteins that link the vitreous to the macula, resulting in posterior detachment of the vitreous from the retina.
|
Classification | Enzyme |
Drug class | plasmin proteins and derivatives |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2095222 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB08888 |
UNII ID | 7V6HE3DM5A (ChemIDplus, GSRS) |